Oppenheimer maintains Perform on INSYS Therapeutics (NASDAQ: INSY).Analyst Derek Archila remains on the sidelines with INSY but does favor the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE